Including a subject‐paced trial may make the PASAT more acceptable for MS patients

Publisher: John Wiley & Sons Inc

E-ISSN: 1600-0404|132|4|219-225

ISSN: 0001-6314

Source: ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol.132, Iss.4, 2015-10, pp. : 219-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract